-
Will Plavix be the next drug up for a genetic test? There are not many alternative drugs either that could easily replace the functionality of Plavix, it is a blood thinner. One idea would be to monitor patients with poor liver or kidney metabolization. as suggested here , a blog written...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
01-02-2009
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Physician, personalized medicine, DNA, Genomics, healthcare, Health IT, Cardiology, Biotech, FDA, Information Overload, Pharmacogenomics, Sequencing, FDA warnings, Plavix
-
Briefly, the test determines if the PTEN gene is functioning properly, as it is a tumor suppressor gene that is linked with cell regulation. If patients have a low level of the protein, studies have shown a progression of the cancer, while if the levels remain higher, the less chances of...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
12-22-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, Genomics, healthcare, Cancer, tumors, Chemotherapy, markers, PTEN gene, Myriad, diagnositic tests
-
If you are not aware of how much leading research comes from the facility, check back on a few posts I have done in the past, the HHMI makes a lot of research possible without the red tape and strings that perhaps come along with grants and restrictions from other investors. With the slowing...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-20-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Genomics, healthcare, Harvard Medical School, Budget Cuts, Charity, Research and Development, Medical Research, Fund raising, Howard Hughes Medical Institute
-
The American Medical Association administration recommends that genetic testing be carried out under the personal supervision of a qualified health care professional, but the lines get a bit gray in between what is actual clinical credible data and what is still science. Education of both the physicians...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-04-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, personalized medicine, Genomics, healthcare, Science, AMA, DNA Testing, Sequencing, Lab Tests, genetic counselors
-
This is a genomics blood test that takes about 6 weeks to run and get the results. The test will identify the specific gene mutation and help with treatment plans and add more input on whether or not family members might be as risk as well. BD NEW YORK (GenomeWeb News) – Clinical Data...
-
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-13-2008
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
-
This is just the start here and it seems to appear the marketing of genomic testing and labs is beginning to resemble the CT scanner rage of a few years ago, except this process is a bit more complicated and still needs more education from the medical side of the business before successful marketing...
-
From Harvard, the goals to help educate both the public and physicians on personal genetics. You can also reference some prior posts with relative information here . Further reading here will help distinguish the difference as to what is on the market today and what you can expect from various...
-
We all recently heard about the warning letters sent from the state of California to firms selling online personal DNA sequencing over the Internet, and requiring a physician’s prescription for the service. One company DeCode, has taken the letter to heart and is revising their marketing plant...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-12-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, DNA, Genomics, Sequence, Pharmacogenomics, Diagnostics, CPT, DeCode
-
When will it start paying the bills? The science and development is somewhat fragmented like the rest of health care, and this is not to say in any way that phenomenal breakthroughs are not occurring by any means as they are. Part of the problem is having enough data, real time data for one...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-03-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, My Commentaries, Physician, personalized medicine, DNA, Genomics, healthcare, Science, Pharmacogenomics
-
A couple weeks ago I had a couple posts referencing the partner ship with Anthem Blue Cross with utilizing their data bases for such a project as well...The new FDA white paper, titled "The Sentinel Initiative -- A National Strategy for Monitoring Medical Product Safety," ... totally amazing...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-22-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, My Commentaries, Genomics, healthcare, Health IT, Security, FDA, clinical trials, Medicare Part D, HL7, data bases